Dr. Thomas Nylk, M.D.
Cardiology (Cardiovascular Disease Physician)
Who else practices at this address →
Washoe County includes primary care (2% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 34
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,235
Licensed in California since 2004, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
NV license 12300 · CA license A89193 (first issued 2004; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Renown Regional Medical Center Reno, NV
- Northern Nevada Medical Center Sparks, NV
- Banner Lassen Medical Center Susanville, CA
- Northern Inyo Hospital Bishop, CA
- Eastern Plumas Hospital - Portola Campus Portola, CA
Medical groups
- Reno Heart Institute Desai PC (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,235
- Services billed
- 2,971
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 790 | 506 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 439 | 423 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 344 | 311 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 240 | 75 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 185 | 57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 173 | 159 |
| New patient office or other outpatient visit, 45-59 minutes | 121 | 121 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 90 | 13 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 89 | 14 |
| Telephone medical discussion with physician, 21-30 minutes | 81 | 69 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 25 payments worth $2,204 in total to this clinician.
| Angiodynamics, Inc. | $1,600 |
|---|---|
| Edwards Lifesciences Corporation | $250 |
| Novartis Pharmaceuticals Corporation | $136 |
| Pfizer Inc. | $66.46 |
| United Therapeutics Corporation | $59.23 |
| Novo Nordisk Inc | $28.07 |
| Boston Scientific Corporation | $23.21 |
| Actelion Pharmaceuticals US, Inc. | $21.72 |
| Long term medical supply or device loan | $1,600 |
|---|---|
| Food and Beverage | $604 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Angiodynamics, Inc. Dec 31, 2025 | Long term medical supply or device loan VenaCure 1470 Pro · ID · in-kind | $1,600 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.